KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Equity Average (2016 - 2025)

Exact Sciences has reported Equity Average over the past 15 years, most recently at $2.5 billion for Q4 2025.

  • Quarterly Equity Average fell 12.65% to $2.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, down 12.65% year-over-year, with the annual reading at $2.4 billion for FY2025, 13.42% down from the prior year.
  • Equity Average was $2.5 billion for Q4 2025 at Exact Sciences, down from $2.5 billion in the prior quarter.
  • Over five years, Equity Average peaked at $3.6 billion in Q2 2021 and troughed at $2.4 billion in Q1 2025.
  • The 5-year median for Equity Average is $3.1 billion (2023), against an average of $3.0 billion.
  • Year-over-year, Equity Average surged 93.93% in 2021 and then decreased 23.56% in 2025.
  • A 5-year view of Equity Average shows it stood at $3.4 billion in 2021, then dropped by 10.13% to $3.1 billion in 2022, then grew by 1.87% to $3.1 billion in 2023, then dropped by 10.43% to $2.8 billion in 2024, then dropped by 12.65% to $2.5 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Equity Average are $2.5 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.4 billion (Q2 2025).